Expression profiling of formalin-fixed paraffin-embedded primary breast tumors using cancer-specific and whole genome gene panels on the DASL®platform
Authors:
- Monica M ReinholzMRMonica M Reinholz
- Jeanette E Eckel-PassowJEJeanette E Eckel-Passow
- S Keith AndersonSAS Keith Anderson
- Yan W AsmannYAYan W Asmann
- Michael A ZschunkeMZMichael A Zschunke
- Ann L ObergAOAnn L Oberg
- Ann E McCulloughAMAnn E McCullough
- Amylou C DueckADAmylou C Dueck
- Beiyun ChenBCBeiyun Chen
- Craig S AprilCACraig S April
- Eliza Wickham-GarciaEWEliza Wickham-Garcia
- Robert B JenkinsRJRobert B Jenkins
Open Access
- 20 December 2010
- journal article
- Published by Springer Nature in BMC Medical Genomics
- Vol. 3 (1) , 60
Abstract
The cDNA-mediated Annealing, extension, Selection and Ligation (DASL) assay has become a suitable gene expression profiling system for degraded RNA from paraffin-embedded tissue. We examined assay characteristics and the performance of the DASL 502-gene Cancer Panelv1 (1.5K) and 24,526-gene panel (24K) platforms at differentiating nine human epidermal growth factor receptor 2- positive (HER2+) and 11 HER2-negative (HER2-) paraffin-embedded breast tumors.Keywords
This publication has 43 references indexed in Scilit:
- Gene-Expression Signatures in Breast CancerNew England Journal of Medicine, 2009
- Gene Expression Signatures, Clinicopathological Features, and Individualized Therapy in Breast CancerJAMA, 2008
- Quantitative Expression Profiling of RNA from Formalin-Fixed, Paraffin-Embedded Tissues Using Randomly Assembled Bead Arrays2008
- The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurementsNature Biotechnology, 2006
- Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypesHuman Pathology, 2006
- Oncogenic pathway signatures in human cancers as a guide to targeted therapiesNature, 2005
- A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast CancerNew England Journal of Medicine, 2004
- A Gene-Expression Signature as a Predictor of Survival in Breast CancerNew England Journal of Medicine, 2002
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences, 2001